Back
Amplify Lithium & Battery Technology ETF Vs. Novo Nordisk AS Industry Stock Comparison
Buy
53
BATT
Amplify Lithium & Battery Technology ETF
Last Price:
$8.88
Seasonality Move:
-5.78%
Sell
22
NVO
Novo Nordisk AS
Last Price:
$85.44
Seasonality Move:
6.4%
Buy
53
Amplify Lithium & Battery Technology ETF (BATT)
is a Buy
Is Amplify Lithium & Battery Technology ETF a Buy, Sell or Hold?
-
The current Amplify Lithium & Battery Technology ETF [BATT] share price is $9.09. The Score for BATT is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
BATT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
22
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NVO] share price is $83.34. The Score for NVO is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BATT Stock Price Chart
What is Amplify Lithium & Battery Technology ETF's stock price today?
-
The Amplify Lithium & Battery Technology ETF share price today is $9.09Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BATT is experiencing selling pressure, which indicates risk of future bearish movement.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $83.34Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight selling pressure.
BATT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.08 | Sell |
Relative Strength Index (14 RSI): | 47.14 | Sell |
Chaikin Money Flow: | -35597 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.02 - 9.46) | Sell |
Bollinger Bands (100): | (8.59 - 9.57) | Buy |
NVO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.21 | Sell |
Relative Strength Index (14 RSI): | 25.67 | Sell |
Chaikin Money Flow: | -3025364 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (87.74 - 109.92) | Sell |
Bollinger Bands (100): | (100.14 - 129.96) | Sell |
BATT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.05 | Buy |
20-day SMA: | 9.21 | Sell |
50-day SMA: | 9.29 | Sell |
200-day SMA: | 9.1 | Sell |
8-day EMA: | 9.07 | Buy |
20-day EMA: | 9.15 | Sell |
50-day EMA: | 9.21 | Sell |
200-day EMA: | 9.33 | Sell |
NVO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 86.29 | Sell |
20-day SMA: | 96.22 | Sell |
50-day SMA: | 103.1 | Sell |
200-day SMA: | 123.96 | Sell |
8-day EMA: | 87.14 | Sell |
20-day EMA: | 93.38 | Sell |
50-day EMA: | 102.27 | Sell |
200-day EMA: | 115.1 | Sell |
Amplify Lithium & Battery Technology ETF Earnings Growth & BATT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.75 per share, and an increase next year of $0.55 per share.
Amplify Lithium & Battery Technology ETF Technical Analysis
Dec 20 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
20 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |